234 related articles for article (PubMed ID: 36355572)
1. Somatic IDH1 Hotspot Variants in Chinese Patients With Pheochromocytomas and Paragangliomas.
Li M; He Y; Pang Y; Zhang J; Feng Y; He Y; Xu X; Wei Y; Zhong D; Deng W; Wang L; Yan B; Jiang Y; Xu N; Cai H; Wen Y; Ning J; Liu Y; Gao X; Shan Z; Liu L; Teng X; Richter S; Jiang J
J Clin Endocrinol Metab; 2023 Apr; 108(5):1215-1223. PubMed ID: 36355572
[TBL] [Abstract][Full Text] [Related]
2. Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma.
Jiang J; Zhang J; Pang Y; Bechmann N; Li M; Monteagudo M; Calsina B; Gimenez-Roqueplo AP; Nölting S; Beuschlein F; Fassnacht M; Deutschbein T; Timmers HJLM; Åkerström T; Crona J; Quinkler M; Fliedner SMJ; Liu Y; Guo J; Li X; Guo W; Hou Y; Wang C; Zhang L; Xiao Q; Liu L; Gao X; Burnichon N; Robledo M; Eisenhofer G
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32750708
[TBL] [Abstract][Full Text] [Related]
3. Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations.
Zhang J; Jiang J; Luo Y; Li X; Lu Z; Liu Y; Huang J; Hou Y; Pang Y; Sun MYF; Wang TS; Evans DB; Pacak K; Zhuang Z; Gao X
Endocrine; 2018 Aug; 61(2):216-223. PubMed ID: 29846902
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas.
Pamporaki C; Hamplova B; Peitzsch M; Prejbisz A; Beuschlein F; Timmers HJLM; Fassnacht M; Klink B; Lodish M; Stratakis CA; Huebner A; Fliedner S; Robledo M; Sinnott RO; Januszewicz A; Pacak K; Eisenhofer G
J Clin Endocrinol Metab; 2017 Apr; 102(4):1122-1132. PubMed ID: 28324046
[TBL] [Abstract][Full Text] [Related]
5. Genetic Characteristics of Incidental Pheochromocytoma and Paraganglioma.
Zhang J; Li M; Pang Y; Wang C; Wu J; Cheng Z; Li X; Lu Z; Liu Y; Guo J; Chen X; He Y; Guan X; Xu X; Wang Y; Liu J; Guo W; Hou Y; Liu L; Jiang J; Gao X
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1835-e1842. PubMed ID: 35106577
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
7. CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.
Turkova H; Prodanov T; Maly M; Martucci V; Adams K; Widimsky J; Chen CC; Ling A; Kebebew E; Stratakis CA; Fojo T; Pacak K
Endocr Pract; 2016 Mar; 22(3):302-14. PubMed ID: 26523625
[TBL] [Abstract][Full Text] [Related]
8. Germline DLST Variants Promote Epigenetic Modifications in Pheochromocytoma-Paraganglioma.
Buffet A; Zhang J; Rebel H; Corssmit EPM; Jansen JC; Hensen EF; Bovée JVMG; Morini A; Gimenez-Roqueplo AP; Hes FJ; Devilee P; Favier J; Bayley JP
J Clin Endocrinol Metab; 2021 Jan; 106(2):459-471. PubMed ID: 33180916
[TBL] [Abstract][Full Text] [Related]
9. Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients.
Calsina B; Currás-Freixes M; Buffet A; Pons T; Contreras L; Letón R; Comino-Méndez I; Remacha L; Calatayud M; Obispo B; Martin A; Cohen R; Richter S; Balmaña J; Korpershoek E; Rapizzi E; Deutschbein T; Vroonen L; Favier J; de Krijger RR; Fassnacht M; Beuschlein F; Timmers HJ; Eisenhofer G; Mannelli M; Pacak K; Satrústegui J; Rodríguez-Antona C; Amar L; Cascón A; Dölker N; Gimenez-Roqueplo AP; Robledo M
Genet Med; 2018 Dec; 20(12):1652-1662. PubMed ID: 30008476
[TBL] [Abstract][Full Text] [Related]
10. Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.
Welander J; Andreasson A; Juhlin CC; Wiseman RW; Bäckdahl M; Höög A; Larsson C; Gimm O; Söderkvist P
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1352-60. PubMed ID: 24694336
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
[TBL] [Abstract][Full Text] [Related]
12. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
Gaal J; Burnichon N; Korpershoek E; Roncelin I; Bertherat J; Plouin PF; de Krijger RR; Gimenez-Roqueplo AP; Dinjens WN
J Clin Endocrinol Metab; 2010 Mar; 95(3):1274-8. PubMed ID: 19915015
[TBL] [Abstract][Full Text] [Related]
13. Somatic EPAS1 Variants in Pheochromocytoma and Paraganglioma in Patients With Sickle Cell Disease.
White G; Nonaka D; Chung TT; Oakey RJ; Izatt L
J Clin Endocrinol Metab; 2023 Nov; 108(12):3302-3310. PubMed ID: 37285480
[TBL] [Abstract][Full Text] [Related]
14. Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma.
Richter S; Gieldon L; Pang Y; Peitzsch M; Huynh T; Leton R; Viana B; Ercolino T; Mangelis A; Rapizzi E; Menschikowski M; Aust D; Kroiss M; Beuschlein F; Gudziol V; Timmers HJ; Lenders J; Mannelli M; Cascon A; Pacak K; Robledo M; Eisenhofer G; Klink B
Genet Med; 2019 Mar; 21(3):705-717. PubMed ID: 30050099
[TBL] [Abstract][Full Text] [Related]
15. Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.
Choi H; Kim KJ; Hong N; Shin S; Choi JR; Kang SW; Lee ST; Rhee Y
Endocrinol Metab (Seoul); 2020 Dec; 35(4):858-872. PubMed ID: 33397040
[TBL] [Abstract][Full Text] [Related]
16. H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.
Oudijk L; de Krijger RR; Rapa I; Beuschlein F; de Cubas AA; Dei Tos AP; Dinjens WN; Korpershoek E; Mancikova V; Mannelli M; Papotti M; Vatrano S; Robledo M; Volante M
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1376-80. PubMed ID: 24684458
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
[TBL] [Abstract][Full Text] [Related]
18. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
[TBL] [Abstract][Full Text] [Related]
19. Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.
Toledo RA; Qin Y; Cheng ZM; Gao Q; Iwata S; Silva GM; Prasad ML; Ocal IT; Rao S; Aronin N; Barontini M; Bruder J; Reddick RL; Chen Y; Aguiar RC; Dahia PL
Clin Cancer Res; 2016 May; 22(9):2301-10. PubMed ID: 26700204
[TBL] [Abstract][Full Text] [Related]
20. Genetic spectrum in a Canadian cohort of apparently sporadic pheochromocytomas and paragangliomas: New data on multigene panel retesting over time.
Parisien-La Salle S; Dumas N; Bédard K; Jolin J; Moramarco J; Lacroix A; Lévesque I; Burnichon N; Gimenez-Roqueplo AP; Bourdeau I
Clin Endocrinol (Oxf); 2022 Jun; 96(6):803-811. PubMed ID: 34750850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
